Careers

Bringing entrepreneurship to economically disadvantaged areas is one of the goals of an entrepreneurship initiative established by the Kauffman Foundation, and the University of Wisconsin-Madison is one of eight campuses selected to participate in the program. To help make it happen, the university has received...

Last month, Nobel-prize winning economist Milton Friedman passed away, and columnist Tony DiRomualdo recalls how Friedman ferociously argued that individuals, aided by free markets, could make better decisions than bureaucracies. In this edition of Next Generation, he examines a concept that would no doubt please...

On December 6, Charlie Hoslet, director of the UW-Madison Office of Corporate Relations, and Paul Pucci, manger of the WiSys Technology Foundation, will hold court in Wausau to describe how north central Wisconsin businesses can take advantage of the university system's resources....

As is the case with most rankings, California dwarfs most Midwestern states in various measures of nanotechnology activity, but the Midwest is still a player in nanotech, writes columnist Michael Rosen. In this edition of Yer Biotech Blues, Rosen takes measure of the Midwest's role...

The nuts and bolts of starting a business include choosing a business entity name, which is more involved than it sounds. Fortunately, the Internet provides a way to find out if you have "naming rights" in Wisconsin, according to Early Stage columnist Joe Boucher, and...

Sonic Foundry Inc., a rich media communications developer headquartered in Madison, generated more than $400,000 in positive cash flow in the fourth quarter and has developed a new IP media search feature after 15 years and $30 million of R&D....

The saying ”what goes around comes around” comes to mind as the dotcom era buzz phrase, “The War for Talent,” makes a comeback. In this Next Generation article, columnist Tony DiRomualdo critiques a special report on key talent market trends, and debates one of its...

The end of a once promising partnership with Pfizer has not dissuaded a Madison biotechnology company from pursuing ways to bring drugs to market faster and more cost effectively. Deltanoid Pharmaceuticals, which was spun out of the University of Wisconsin-Madison, is pursuing Phase II funding...

An electronic database that uses Web-based tools to connect privately held companies with board candidates has thus far been focused on Wisconsin, but sponsors of DirectorConnector have been approached about taking the service national. Since launching in 2004, the free service has connected 146 board...